Skip to main content
. 2020 May;82(2):323–333. doi: 10.18999/nagjms.82.2.323

Supplementary table.

PFASs concentrations in sera (ng/mL) of all patients in this study

Percent Percentile
PFASs LOD >LOD (%) Minimum 25th Median 75th Maximum
PFBS 0.009 100 0.07 0.10 0.14 0.22 2.38
PFHpA 0.03 100 0.09 0.17 0.25 0.48 0.95
PFHxS 0.02 100 0.13 0.34 0.62 1.82 4.96
PFOA 0.09 100 2.05 8.05 13.89 21.37 360.50
PFOS 0.09 100 0.73 2.48 4.47 8.26 76.76
PFNA 0.02 100 0.38 0.83 1.54 2.37 15.72
PFDA 0.02 100 0.08 0.35 0.74 1.38 14.60
PFUA 0.02 100 0.03 0.20 0.51 0.75 5.22
PFOSA 0.12 46.43 0.09 0.09 0.11 0.12 0.83
PFDoA 0.05 98.81 0.04 0.10 0.13 0.17 1.08